Solara Active Pharma Sciences intimated a panel change for its analyst/investor conference call scheduled for May 15, 2026.
The call will discuss the company's audited financial results for the quarter and year ended March 31, 2026.
Management participants include MD & CEO Sandeep Rao and CFO Sarat Kumar for the 3:00 PM IST group meet.
The company confirmed the update is for transparency and compliance, with no other call details changed.